Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 372.10M | 389.06M | 310.58M | 266.80M | 252.76M | 183.22M |
Gross Profit | 210.14M | 235.86M | 178.56M | 180.46M | 189.05M | 138.70M |
EBITDA | -358.82M | -311.82M | -306.92M | -284.40M | -190.93M | -55.96M |
Net Income | -342.64M | -288.70M | -279.70M | -268.84M | -192.06M | -55.70M |
Balance Sheet | ||||||
Total Assets | 968.74M | 1.03B | 1.04B | 1.10B | 1.17B | 1.20B |
Cash, Cash Equivalents and Short-Term Investments | 711.90M | 742.69M | 750.37M | 730.98M | 960.16M | 1.09B |
Total Debt | 0.00 | 60.29M | 3.23M | 2.34M | 3.61M | 5.63M |
Total Liabilities | 169.91M | 187.58M | 164.87M | 173.36M | 181.41M | 135.30M |
Stockholders Equity | 798.82M | 838.30M | 873.35M | 929.66M | 989.48M | 1.06B |
Cash Flow | ||||||
Free Cash Flow | -85.86M | -44.45M | -90.37M | -187.21M | -90.75M | -39.18M |
Operating Cash Flow | -82.98M | -41.41M | -62.36M | -115.69M | -86.46M | -37.55M |
Investing Cash Flow | 6.78M | 16.40M | -66.61M | 59.95M | 317.01M | -767.15M |
Financing Cash Flow | 23.33M | 22.22M | 11.29M | 621.00K | 5.71M | 887.36M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | 69.92B | 22.03 | 28.18% | 3.07% | 4.52% | -0.22% | |
76 Outperform | 7.44B | 14.16 | 20.81% | 1.59% | 7.37% | -14.64% | |
74 Outperform | 148.91B | 19.67 | 24.61% | 2.55% | 7.36% | 6.18% | |
74 Outperform | 33.39B | 13.88 | 15.93% | 1.84% | 6.34% | 12.16% | |
68 Neutral | 8.71B | 21.39 | 10.94% | ― | 9.73% | -0.29% | |
43 Neutral | $2.50B | ― | -40.94% | ― | 14.34% | -13.27% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |
C3 AI announced the appointment of Stephen Ehikian as its new Chief Executive Officer, effective September 1, 2025. Ehikian, a seasoned technology leader with a history of building and scaling AI companies, is expected to drive C3 AI’s growth and market penetration in the enterprise AI sector. His appointment is seen as a strategic move to enhance the company’s leadership in AI applications for commercial and government markets, with Thomas M. Siebel continuing as Executive Chairman.
On July 21, 2025, C3.ai announced the initiation of a search for a new Chief Executive Officer to succeed Thomas M. Siebel, who will transition to the role of Executive Chairman. This decision follows Mr. Siebel’s diagnosis with an autoimmune disease, which has led to significant visual impairment. The move aims to ensure C3.ai’s continued growth and success, with Mr. Siebel remaining engaged until a successor is appointed.